BioNexus Gene Lab Names CFO Chong Set Fui in Initial Beneficial Ownership Filing
BioNexus Gene Lab Corp filed an initial Form 3 for CFO Chong Set Fui on June 17, 2025, disclosing beneficial ownership details to the U.S. Securities and Exchange Commission.
Bitget · 2026-08-01 08:39